Skip to main content
Centre for Commercial Law Studies

The unequal scramble for coronavirus vaccines – by the numbers

Professor Duncan Matthews interviewed in Nature


Wealthy countries have struck deals to buy more than two billion doses of coronavirus vaccine in a scramble that could leave limited supplies in the coming year. Meanwhile, an international effort to acquire vaccines for low- and middle-income countries is struggling to gain traction. Duncan Matthews, Professor of Intellectual Property Law at Queen Mary University of London, explains to Nature why the situation is so uncertain.



Back to top